ALFA Filings
Every announcement, straight from the exchange
Every Elpro International acquisition announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
Elpro International’s subsidiary acquired a 100% stake in Quest Academy Limited for ₹186.12 Crore. This acquisition expands the company’s real estate portfolio.
Elpro International acquired 92,000 equity shares in Jana Small Finance Bank for ₹4.48 Crore. The investment aligns with the company's financial services portfolio and investment strategy.
Elpro International Limited has acquired a stake in Cohance Lifesciences Limited for ₹4.79 Crore in cash. Cohance Lifesciences is a pharmaceutical platform specializing in CDMO, APIs, and specialty chemicals. The acquisition is intended for investment purposes, allowing Elpro to gain exposure to the pharmaceutical and specialty chemicals sectors.
Elpro International Ltd acquired 1,33,086 equity shares of Cohance Lifesciences Limited for ₹4.79 Crore. This fresh acquisition brings its total holding to 2,48,813 shares. The investment aligns with its objective of holding pharmaceutical assets for investment purposes.
Elpro International Ltd acquired 1,06,000 equity shares of DLF Limited for a cash consideration of ₹6.01 Crore. The acquisition, intended for investment purposes, represents a fresh holding in the real estate major. DLF reported a consolidated turnover of ₹8,995.89 Crore for FY 2024-25.
Elpro International Ltd acquired 1,36,000 equity shares of Ambuja Cements Limited for ₹6.02 Crore. The acquisition was made for investment purposes and does not constitute a related party transaction. This represents a fresh investment in the cement sector by the company.